Compass Point Maintains Buy on Physicians Realty Trust, Lowers Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
Compass Point analyst Merrill Ross has maintained a Buy rating on Physicians Realty Trust (NYSE:DOC) but has lowered the price target from $19 to $18.

January 02, 2024 | 4:07 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Compass Point has reaffirmed a Buy rating on Physicians Realty Trust but reduced the price target from $19 to $18.
While the reaffirmation of a Buy rating is positive, the reduction in price target may reflect a more conservative valuation or anticipated headwinds, which could have a neutral to slightly negative impact on investor sentiment in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100